The Joint Corp
JYNT

$14.30

4.92%

Market Cap: 214M

About: The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

Employees: 794

Financials Patent Owners & Lessors

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

33% more capital invested

Capital invested by funds: $109M [Q4 2023] → $145M (+$35.6M) [Q1 2024]

27% more call options, than puts

Call options by funds: $626K | Put options by funds: $492K

0% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 2 (+0) [Q1 2024]

2.06% less ownership

Funds ownership: 77.13% [Q4 2023] → 75.07% (-2.06%) [Q1 2024]

7% less funds holding

Funds holding: 89 [Q4 2023] → 83 (-6) [Q1 2024]

31% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 35

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

See Fund Rankings

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$16

12%

upside

Avg. target

$18

26%

upside

High target

$20

40%

upside

2 analyst ratings

2 positive

100%

0 neutral

0%

0 negative

0%

B. Riley Securities Jeff Van Sinderen	40%upside $20	Buy Maintained	6 May 2024
Roth MKM George Kelly	12%upside $16	Buy Reiterated	3 May 2024

See Analyst Rankings

Financial journalist opinion

The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results

SCOTTSDALE, Ariz., July 25, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its second quarter 2024 financial results on Thursday, August 8, 2024, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results

The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts

SCOTTSDALE, Ariz., May 13, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, signed an agreement engaging Capstone Partners, a full-service middle market investment bank with specialization in refranchising.

The Joint Corp. Engages Capstone Partners to Accelerate Refranchising Efforts

The Joint Corp. to Participate in Upcoming Investor Conferences

SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that President and Chief Executive Officer Peter Holt and Chief Financial Officer Jake Singleton are scheduled to participate in the following upcoming conferences:

The Joint Corp. to Participate in Upcoming Investor Conferences

The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript

The Joint Corp. (NASDAQ:JYNT ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief Executive Officer Jake Singleton – Chief Financial Officer Conference Call Participants George Kelly – ROTH Anthony Vendetti – Maxim Group C. J. Dipollino – Craig-Hallum Group Operator Good day, and welcome to The Joint Group Corp. First Quarter 2024 Financial Results Conference Call.

The Joint Corp. (JYNT) Q1 2024 Earnings Call Transcript

Zacks Investment Research

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

The Joint Corp. (JYNT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.03 per share. This compares to earnings of $0.15 per share a year ago.

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates

The Joint Corp. Reports First Quarter 2024 Financial Results

- Grew Q1 2024 Revenue 5%, System-wide Sales 9%, and System-wide Comp Sales 3% vs. Q1 2023 - - Opened 23 Franchised Clinics, Increasing Clinic Count to 954 at March 31, 2024 - - Sold 15 Franchise Licenses, Tripling Sales Compared to Q4 2023 -

The Joint Corp. Reports First Quarter 2024 Financial Results

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close.

The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results

The Joint Chiropractic Proudly Supports Colorado-Based Rachel's Challenge

DENVER , April 17, 2024 /PRNewswire/ -- The Joint Chiropractic, the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, is proud to announce a year-long sponsorship of Rachel's Challenge, a non-profit organization for school violence prevention. The Joint is honored to be joining Rachel's Challenge in its vision to create schools full of hope, free from harassment, violence, and self-harm, where teachers are free to teach and students are inspired to learn.

The Joint Chiropractic Proudly Supports Colorado-Based Rachel's Challenge

Logan University Establishes The Joint Chiropractic Endowed Scholarship

ST. LOUIS , April 2, 2024 /PRNewswire/ -- Logan University and The Joint Corp. are proud to establish The Joint Chiropractic Endowed Scholarship for Logan's Doctor of Chiropractic students. This scholarship is aimed at supporting and empowering Logan's exceptional students in their pursuit of higher education.

Logan University Establishes The Joint Chiropractic Endowed Scholarship

Zacks Investment Research

The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?

The Joint Corp. (JYNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

The Joint Corp. (JYNT) Upgraded to Buy: What Does It Mean for the Stock?

See News Rankings